NCT05160480View on ClinicalTrials.gov

A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG

Enrolling by invitationOBSERVATIONAL

Enrollment

9

Participants

Timeline

Start Date

June 7, 2024

Primary Completion Date

September 1, 2025

Study Completion Date

March 1, 2026

Conditions

Prostate CancerBreast CancerNeuroendocrine Tumors

Interventions

DIAGNOSTIC_TEST

Total-body PET imaging

Total-body PET imaging at different timepoints

Trial Locations (1)

95816

UC Davis EXPLORER Molecular Imaging Center, Sacramento

Sponsors

Collaborators (1)

Lantheus Medical Imaging

All Listed Sponsors

collaborator

Lantheus Medical Imaging

INDUSTRY

lead

University of California, Davis

OTHER